arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Kalaris Therapeutics, Inc.

KLRS

$4.06 ▼ -0.06 (-1.34%) at close

30 Visible periods

21 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Kalaris Therapeutics, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $96.3M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -13.6% ↘

FCF / Share $-0.49

Trailing P/E —

Price / Book 1.4x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

30-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

— —

Net Income Profit after all expenses

$-10.86M

↓ -6.5% —

FCF / Share Free cash flow per share

$-0.49

↑ +73.4% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↑

Financial Health ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
EPS Growth YoY (%)	81.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	97.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-1500.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-1120.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-869.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	60.0% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	89.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	89.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	40.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-10924.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	22.0% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	30.4% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	—	59.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	30.6% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-15.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-6.5% Weak ↓ Weak Declining Year-over-year change in net income	54.6% Excellent ↓ Excellent Declining Year-over-year change in net income	66.3% Excellent → Excellent Stable Year-over-year change in net income	66.3% Excellent ↑ Excellent Improving Year-over-year change in net income	66.3% Excellent ↑ Excellent Improving Year-over-year change in net income	63.1% Excellent ↑ Excellent Improving Year-over-year change in net income	26.4% Excellent ↑ Excellent Improving Year-over-year change in net income	26.4% Excellent ↑ Excellent Improving Year-over-year change in net income	26.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-56.5% Weak ↓ Weak Declining Year-over-year change in net income	6.1% Fair ↓ Fair Declining Year-over-year change in net income	6.1% Fair ↑ Fair Improving Year-over-year change in net income	6.1% Fair ↑ Fair Improving Year-over-year change in net income	34.2% Excellent ↑ Excellent Improving Year-over-year change in net income	-41.8% Weak ↑ Weak Improving Year-over-year change in net income	-41.8% Weak ↑ Weak Improving Year-over-year change in net income	-41.8% Weak ↑ Weak Improving Year-over-year change in net income	-129.9% Weak ↑ Weak Improving Year-over-year change in net income	-231.1% Weak ↓ Weak Declining Year-over-year change in net income	-231.1% Weak → Weak Stable Year-over-year change in net income	-231.1% Weak → Weak Stable Year-over-year change in net income	-188.2% Weak ↑ Weak Improving Year-over-year change in net income	-270.0% Weak Weak Year-over-year change in net income	-270.0% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	73.4% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-374.4% Weak Weak Year-over-year change in free cash flow	—	—	—	-12.4% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	28.6% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Effective Tax Rate (%) (%)	—	—	—	—	—	—	—	—	—	0.2% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	1.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.3% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	1.07x Fair → Fair Stable Free cash flow relative to reported net income Optimal: > 1x	0.71x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.11x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.23x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.36x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.46x Good Good Free cash flow relative to reported net income Optimal: > 1x	0.51x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.78x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	—	1.06x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.49x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.18x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.75x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.61x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.13x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	1.03x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	2.54x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Return on Invested Capital (%)	-13.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-24.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	5.8% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	-3.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-21.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-42.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-24.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-17.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-17.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-28.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-22.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-19.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	13.5% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	13.0% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	14.6% Good → Good Stable Return earned on debt + equity capital invested Optimal: > 10%	15.5% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	12.8% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-10.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-15.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-115.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-4.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-22.4% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-32.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-18.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.7% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-17.7% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-14.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-22.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-18.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-19.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-8.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-6.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-15.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-206%)	-12.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-185%)	-24.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-262%)	-19.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-228%)	-16.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-206%)	22.8% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+52%)	-25.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-267%)	-25.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-268%)	-25.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-268%)	-40.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-373%)	-21.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-241%)	-18.0% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-220%)	-21.3% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-242%)	-17.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-213%)	-17.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-215%)	-27.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-285%)	-22.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-253%)	-25.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-271%)	-11.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-177%)	-10.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-168%)	-9.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-162%)	-7.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-148%)	-2.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-117%)	13.1% Fair → Fair Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-13%)	15.6% Good ↑ Good Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	17.0% Good ↑ Good Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+13%)	5.8% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-61%)	6.9% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-54%)	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Interest Coverage (x)	—	—	—	—	-7.18x Weak Weak Operating income divided by interest expense Optimal: > 5x	-5.45x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$-34.43M	$-98.05M	$-42.39M	$-88.43M	$-100.97M	$-1.64M	$-116.86M	$-104.74M	$-86.04M	$-90.12M	$-95.63M	$-196.95M	$-115.70M	$-106.09M	$-123.83M	$-71.09M	$-100.21M	$-201.66M	$-243.19M	$-225.45M	$-168.65M	$-122.66M	$-142.25M	$-78.27M	$-168.60M	$-61.08M	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Basic EPS, GAAP (USD)	$-0.46	$-0.44	$-0.64	$-0.61	$-2.52	$-16.33	$-0.04	$-0.05	$-0.26	$-40.79	$-0.39	$-0.48	$-0.44	$-0.37	$-0.50	$-0.69	—	$-0.92	$-0.72	$-0.60	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.49	—	$-0.61	$-0.67	$-1.84	—	—	—	$-0.39	—	—	—	$-0.34	—	$-0.41	—	—	—	$-0.58	$-0.37	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$2.98	$3.44	$2.24	$2.84	$3.42	$-71.23	$1.05	$1.04	$1.05	$29.37	$1.71	$2.01	$2.07	$2.41	$2.98	$2.44	$2.98	$3.54	$4.25	$4.85	$5.29	$5.70	$6.06	$-25.45	—	$-24.53	—	—	—	—
Tangible Book Value per Share (USD)	$2.98	$3.44	$2.24	$2.84	$3.42	$-71.23	$1.05	$1.04	$1.05	$29.37	$1.71	$2.01	$2.07	$2.41	$2.98	$2.44	$2.98	$3.54	$4.25	$4.85	$5.29	$5.70	$6.06	$-25.45	—	$-24.53	—	—	—	—
Basic Weighted Avg Shares (shares)	23.72M	—	18.70M	18.70M	4.05M	—	115.40M	115.13M	114.69M	—	113.89M	94.63M	93.30M	—	84.95M	64.47M	—	—	62.96M	62.34M	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Working Capital (USD)	$90.39M	$109.09M	$72.12M	$84.00M	$95.04M	$-22.10M	$121.12M	$127.58M	$133.83M	$159.27M	$186.95M	$222.35M	$187.32M	$218.71M	—	$154.93M	$187.80M	$215.50M	—	—	$324.16M	$349.02M	$370.42M	$98.37M	—	$118.21M	—	—	—	—
Total Equity (USD)	$68.56M	$78.81M	$41.87M	$53.12M	$63.87M	$-96.62M	$121.12M	$120.29M	$120.44M	$145.78M	$195.33M	$229.11M	$193.53M	$224.52M	$253.23M	$158.14M	$191.68M	$225.27M	$267.30M	$302.47M	$330.37M	$353.06M	$373.90M	$-71.29M	$-60.02M	$-51.50M	$-43.35M	$-36.65M	$-32.91M	$-30.62M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$0.00	$0.00	—	—	—
Depreciation Expense (USD)	$10.00K	$10.00K	—	—	—	—	—	—	—	$141.00K	—	—	$86.00K	$86.00K	$85.00K	—	$466.00K	$94.00K	$44.00K	$33.00K	$18.00K	$18.00K	—	—	$18.00K	—	—	—	—	—
Net Income, GAAP (USD)	$-10.86M	$-10.00M	$-10.20M	$-10.20M	$-10.20M	$-22.03M	$-30.30M	$-30.30M	$-30.30M	$-59.70M	$-41.18M	$-41.18M	$-41.18M	$-38.14M	$-43.86M	$-43.86M	$-43.86M	$-57.94M	$-30.92M	$-30.92M	$-30.92M	$-25.20M	$-9.34M	$-9.34M	$-9.34M	$-8.74M	$-2.52M	$-2.52M	—	—
Operating Cash Flow (USD)	$-11.58M	$-7.06M	$-11.33M	$-12.54M	$-7.44M	$-7.85M	—	—	$-44.38M	$-30.73M	—	—	$-32.12M	$-31.57M	$-35.13M	—	$-46.48M	$-28.07M	$-36.44M	$-22.89M	$-18.93M	$-21.09M	—	—	$-10.54M	$-8.87M	$-6.40M	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 30 quarters

Kalaris Therapeutics, Inc.

Analytical Summary

30-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare KLRS with peers